TwinBeech Capital’s Ventyx Biosciences VTYX Stock Holding History

TwinBeech Capital’s Portfolio VTYX Stock Details VTYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-82,823	Closed	-$2.77M	–	882
2023 Q1	$2.77M	Buy	+82,823	New	+$3.22M	0.06%	328

Other funds holding VTYX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

TwinBeech Capital's VTYX Position: Q2 2023 in Review

TwinBeech Capital sold out of Ventyx Biosciences (VTYX) in Q2 2023, closing a stake of 82,823 shares — an estimated $2.77M sold.

TwinBeech Capital first reported a position in VTYX in Q1 2023 and held it in 1 quarter. The position peaked at $2.77M in Q1 2023. 150 funds tracked by Wall St. Rank hold VTYX as of Q2 2023.

TwinBeech Capital reported no remaining Ventyx Biosciences position as of Q2 2023 after selling out during the quarter.
TwinBeech Capital sold 82,823 Ventyx Biosciences shares in Q2 2023, an estimated $2.77M.
TwinBeech Capital first reported a position in Ventyx Biosciences in Q1 2023 and held it in 1 quarter.
TwinBeech Capital's Ventyx Biosciences position peaked at $2.77M in Q1 2023.
150 funds tracked by Wall St. Rank held Ventyx Biosciences as of Q2 2023.

Based on TwinBeech Capital's 13F filing for Q2 2023, filed 14 Aug 2023.